These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cyfra 21-1 and TPA as markers in malignant mesothelioma.
    Author: Bonfrer JM, Schouwink JH, Korse CM, Baas P.
    Journal: Anticancer Res; 1997; 17(4B):2971-3. PubMed ID: 9329578.
    Abstract:
    BACKGROUND: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma. MATERIALS AND METHODS: Serum levels of patients were analysed for prognosis of survival and follow up of disease. RESULTS: Cyfra 21-1 and TPA have significant prognostic value for survival. CONCLUSION: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.
    [Abstract] [Full Text] [Related] [New Search]